Login
Toggle navigation
Videos
Categories
Trending
Dr Thomas Meier CEO, Santhera Pharmaceuticals Holding Ltd
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dr Thomas Meier CEO, Santhera Pharmaceuticals Holding Ltd
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Mabel Ryder, M.D. Endocrinologist, Mayo Clinic
00:10:00
Fred Hu, Chairman of Primavera Capital, Discusses Chinese Tech Regulation and Market Impact | Fred Hu, CEO, Primavera Capital Group.
00:10:00
Strategy is to create a tech-forward leader in the building products distribution industry|Brad Jacobs,CEO,Jacobs Private Equity LLC
00:10:00
Toni Townes-Whitley, CEO of Science Applications International Corp. (SAIC), discusses the company's AI investments and fourth-quarter performance.
00:10:00
Embracing Diversity in Brussels: Harold Boël at Digityser's Grand Opening | Harold Boël, CEO, Sofina.
00:10:00
We extremely responsive to our borrower's needs.|Samir Patel,Managing Partner,Trophy Point Capital, LLC
00:10:00
"Innovation, Technology, and AI: Strategic Investment Positioning for Capturing Future Growth Opportunities with BBLAM's Industry Experts"
00:10:00
Biotech Innovator GenXone Seeks PLN 4 Million in Equity Crowdfunding | MichaĆ Kaszuba, CEO, GenXone SA.
00:10:00
Concerns Over Federal Reserve Credibility Amid Inflation Strategy | Scott Sperling, CO-CEO, Thomas H. Lee Partners .
00:10:00
The Nuances of Commercial Real Estate: Insights from an Industry Leader | Michelle M. MacKay, CEO,Cushman & Wakefield PLC.
00:10:00
High Gold Mining: Unearthing Value in North America
00:00:00
Collaborate in the creation of a number of innovative community services/ Barbara Ogur, MD Associate Education Director, HMS